Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Triggered psoriasis.

R Wolf1, V Ruocco

  • 1Department of Dermatology, Tel-Aviv Sourasky Medical Center, Ichilov Hospital, Israel. wolf_r@netvision.net.il

Advances in Experimental Medicine and Biology
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smoking can be good for you.

Journal of cosmetic dermatology·2006
Same author

Influence of cassette type on the DQE of CR systems.

Medical physics·2006
Same author

Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY.

Diabetologia·2006
Same author

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients.

Neurology·2006
Same author

An image quality comparison of standard and dual-side read CR systems for pediatric radiology.

Medical physics·2006
Same author

Impetigo herpetiformis with hyperparathyroidism.

Journal of the European Academy of Dermatology and Venereology : JEADV·2005
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Antimalarials can trigger existing psoriasis by inhibiting transglutaminase (TGase) activity, altering epidermal barrier function. This study confirms hydroxychloroquine sulfate (HCQS) inhibits TGase, suggesting it provokes psoriasis in predisposed individuals.

Area of Science:

  • Dermatology
  • Pharmacology
  • Biochemistry

Background:

  • Conflicting reports exist on antimalarial use in psoriatic patients.
  • Antimalarials are known to trigger psoriasis, unlike lithium or beta-blockers which can induce it de novo.
  • A hypothesis suggests antimalarials trigger psoriasis by modulating transglutaminase (TGase) activity due to structural similarities with TGase inhibitors.

Purpose of the Study:

  • To investigate the effect of hydroxychloroquine sulfate (HCQS) on cultured human skin and TGase activity.
  • To verify the hypothesis that antimalarials trigger psoriasis via TGase modulation.

Main Methods:

  • Review of 18 English-language publications on antimalarials and psoriasis.
  • In vitro experiments using cultured human skin explants.

Related Experiment Videos

  • Assay of TGase activity in the presence of varying concentrations of HCQS.
  • Main Results:

    • Significant changes in epidermal morphology were observed in skin explants treated with HCQS.
    • HCQS demonstrated a concentration-dependent inhibition of TGase activity.
    • Antimalarials were found to trigger, rather than induce de novo, psoriasis in most cases.

    Conclusions:

    • HCQS inhibits TGase activity, potentially disrupting the epidermal barrier function.
    • This disruption triggers a physiological response leading to epidermal proliferation, which may manifest as psoriasis in susceptible individuals.
    • Antimalarials primarily act as triggers for latent psoriasis, not as primary inducers.